Cargando…

Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers

Detalles Bibliográficos
Autores principales: Chen, Nianhang, Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643567/
http://dx.doi.org/10.1007/s00280-014-2516-7
_version_ 1782400538001801216
author Chen, Nianhang
Weiss, Daniel
Reyes, Josephine
Liu, Liangang
Kasserra, Claudia
Wang, Xiaomin
Zhou, Simon
Kumar, Gondi
Weiss, Lilia
Palmisano, Maria
author_facet Chen, Nianhang
Weiss, Daniel
Reyes, Josephine
Liu, Liangang
Kasserra, Claudia
Wang, Xiaomin
Zhou, Simon
Kumar, Gondi
Weiss, Lilia
Palmisano, Maria
author_sort Chen, Nianhang
collection PubMed
description
format Online
Article
Text
id pubmed-4643567
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-46435672015-11-19 Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers Chen, Nianhang Weiss, Daniel Reyes, Josephine Liu, Liangang Kasserra, Claudia Wang, Xiaomin Zhou, Simon Kumar, Gondi Weiss, Lilia Palmisano, Maria Cancer Chemother Pharmacol Erratum Springer Berlin Heidelberg 2014-08-01 2014 /pmc/articles/PMC4643567/ http://dx.doi.org/10.1007/s00280-014-2516-7 Text en © Springer-Verlag Berlin Heidelberg 2014
spellingShingle Erratum
Chen, Nianhang
Weiss, Daniel
Reyes, Josephine
Liu, Liangang
Kasserra, Claudia
Wang, Xiaomin
Zhou, Simon
Kumar, Gondi
Weiss, Lilia
Palmisano, Maria
Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title_full Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title_fullStr Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title_full_unstemmed Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title_short Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers
title_sort erratum to: no clinically significant drug interactions between lenalidomide and p-glycoprotein substrates and inhibitors: results from controlled phase i studies in healthy volunteers
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643567/
http://dx.doi.org/10.1007/s00280-014-2516-7
work_keys_str_mv AT chennianhang erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT weissdaniel erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT reyesjosephine erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT liuliangang erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT kasserraclaudia erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT wangxiaomin erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT zhousimon erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT kumargondi erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT weisslilia erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers
AT palmisanomaria erratumtonoclinicallysignificantdruginteractionsbetweenlenalidomideandpglycoproteinsubstratesandinhibitorsresultsfromcontrolledphaseistudiesinhealthyvolunteers